Lumexa Imaging Holdings Inc(LMRI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 4:00 PM ET (Korea 10/31 05:00)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | - | Insider Own | 73.39% | Shs Outstand | 96.1M | Perf Week | -2.14% |
| Market Cap | 1.10B | Forward P/E | 13.74 | EPS next Y | 29.32% | Insider Trans | 0.09% | Shs Float | 25.6M | Perf Month | 12.97% |
| Enterprise Value | 2.00B | PEG | - | EPS next Q | 0.16 | Inst Own | 35.3% | Short Float | 7.5% | Perf Quarter | 1.33% |
| Income | - | P/S | - | EPS this Y | 197.3% | Inst Trans | 0.31% | Short Ratio | 4.65 | Perf Half Y | 14.1% |
| Sales | - | P/B | 1.78 | EPS next 5Y | - | ROA | - | Short Interest | 1.92M | Perf YTD | -38.32% |
| Book/sh | 6.4 | P/C | 15.73 | EPS past 3/5Y | 38.42% - | ROE | - | 52W High | -41.34% ($19.45) | Perf Year | - |
| Cash/sh | 0.73 | P/FCF | - | Sales past 3/5Y | 4.55% - | ROIC | - | 52W Low | 76.9% ($6.45) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 3.9% 4.16% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.48 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.42 | EPS Q/Q | 110.79% | Profit Margin | - | RSI (14) | 57.37 | Recom | 1.1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.42 | Sales Q/Q | 6.5% | SMA20 | 4.07% ($10.96) | Beta | - | Target Price | $17.67 |
| Payout | - | Debt/Eq | 1.59 | Earnings | 2026/11/10 | SMA50 | 2.72% ($11.11) | Rel Volume | 0.59 | Prev Close | $11.73 |
| Employees | 5019 | LT Debt/Eq | 1.52 | EPS/Sales Surpr. | 34.86% 0.4% | SMA200 | 2.81% ($11.1) | Avg Volume(3M) | 0.41M | Price | $11.41 |
| IPO | 2025/12/11 | Option/Short | No/Yes | Trades | 3036 | Volume | 244,495 | Change | -2.73% |
Lumexa Imaging Holdings (LMRI) is a medical imaging services company that operates outpatient diagnostic imaging centers across the United States. It offers a broad range of diagnostic exams, ranging from advanced imaging such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) to X-rays, ultrasound, and mammography. With its network of centers spanning multiple states and an extensive base of referring physicians, the company has established itself as a sizable player in the outpatient imaging market.
Over the past 1 year, roughly in the middle
41% below its 1-year high.
Traded less than usual. That is 59% of its average volume.
Next earnings report: November 10
10 days to go.
Earnings are growing steadily
Earnings are expected to grow by +197.3% this year.
Tap to view numbers
Not enough quarters to judge yet
Only 2 quarter(s) reported, so no grade yet.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Long-term returns are roughly flat
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 35.3%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #39 of 142 in the industry
Based on market cap of $1B.
BVS#36 Bioventus Inc $1B PER 17.2 
AORT#37 Artivion Inc $1B PER - 
PRCT#38 Procept BioRobotics Corp $1B PER - LMRI#39 Lumexa Imaging Holdings Inc $1B PER - 
ATEC#40 Alphatec Holdings Inc $1B PER - 
FAQ
What kind of company is LMRI?
LMRI belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of LMRI?
The market cap of LMRI is approximately $1.1B, ranking 2,502 within its sector.
What is the 52-week high and low for LMRI?
LMRI has recorded a 52-week high of $19.45 and a low of $6.45.
